These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 34839295)

  • 21. Clinical and Epidemiological Features of SARS-CoV-2 Patients in SARI Ward of a Tertiary Care Centre in New Delhi.
    Aggarwal A; Shrivastava A; Kumar A; Ali A
    J Assoc Physicians India; 2020 Jul; 68(7):19-26. PubMed ID: 32602676
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
    Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
    Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of Sleep-Related Hypoxia With Risk of COVID-19 Hospitalizations and Mortality in a Large Integrated Health System.
    Pena Orbea C; Wang L; Shah V; Jehi L; Milinovich A; Foldvary-Schaefer N; Chung MK; Mashaqi S; Aboussouan L; Seidel K; Mehra R
    JAMA Netw Open; 2021 Nov; 4(11):e2134241. PubMed ID: 34757409
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Considerations for target oxygen saturation in COVID-19 patients: are we under-shooting?
    Shenoy N; Luchtel R; Gulani P
    BMC Med; 2020 Aug; 18(1):260. PubMed ID: 32814566
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Asymptomatic hypoxia in COVID-19 is associated with poor outcome.
    Brouqui P; Amrane S; Million M; Cortaredona S; Parola P; Lagier JC; Raoult D
    Int J Infect Dis; 2021 Jan; 102():233-238. PubMed ID: 33130200
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of the predictors and frequency of silent hypoxemia in COVID-19 patients and the gap between pulse oximeter and arterial blood gas levels: A cross-sectional study.
    Fallahi MJ; Pezeshkian F; Ranjbar K; Javaheri R; Shahriarirad R
    Health Care Sci; 2024 Jun; 3(3):172-180. PubMed ID: 38947362
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of High-Flow Nasal Cannula for Acute Dyspnea and Hypoxemia in the Emergency Department.
    Rittayamai N; Tscheikuna J; Praphruetkit N; Kijpinyochai S
    Respir Care; 2015 Oct; 60(10):1377-82. PubMed ID: 26060321
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Syncope and silent hypoxemia in COVID-19: Implications for the autonomic field.
    Baker J; Incognito AV; Wilson RJA; Raj SR
    Auton Neurosci; 2021 Nov; 235():102842. PubMed ID: 34246957
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intensive care for seriously ill patients affected by novel coronavirus sars - CoV - 2: Experience of the Crema Hospital, Italy.
    Zuccon W; Comassi P; Adriani L; Bergamaschini G; Bertin E; Borromeo R; Corti S; De Petri F; Dolci F; Galmozzi A; Gigliotti A; Gualdoni L; Guerra C; Khosthiova A; Leati G; Lupi G; Moscato P; Perotti V; Piantelli M; Ruini A; Sportelli S; Susca M; Troiano C; Benelli G; Buscarini E; Canetta C; Merli G; Scartabellati A; Melilli B S C G; Sfogliarini R; Pellegatta G; Viganò G
    Am J Emerg Med; 2021 Jul; 45():156-161. PubMed ID: 33046317
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical and radiological findings of silent hypoxia among COVID-19 patients.
    Okuhama A; Ishikane M; Hotta M; Sato L; Akiyama Y; Morioka S; Suzuki S; Tajima T; Yamamoto M; Teruya K; Izumi S; Ohmagari N
    J Infect Chemother; 2021 Oct; 27(10):1536-1538. PubMed ID: 34294527
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Management of hypoxemia in SARS-CoV-2 infection: Lessons learned from one year of experience, with a special focus on silent hypoxemia.
    Serrano R; Corbella X; Rello J
    J Intensive Med; 2021 Jul; 1(1):26-30. PubMed ID: 36943810
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Radiographic and clinical neurologic manifestations of COVID-19 related hypoxemia.
    Radnis C; Qiu S; Jhaveri M; Da Silva I; Szewka A; Koffman L
    J Neurol Sci; 2020 Nov; 418():117119. PubMed ID: 32957036
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predictors of silent hypoxia in hospitalized patients with COVID-19 in Japan.
    Hayakawa K; Morioka S; Asai Y; Tsuzuki S; Yamada G; Suzuki S; Matsunaga N; Ohmagari N
    J Infect Chemother; 2022 Oct; 28(10):1436-1438. PubMed ID: 35725530
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Patient characteristics, clinical course and factors associated to ICU mortality in critically ill patients infected with SARS-CoV-2 in Spain: A prospective, cohort, multicentre study.
    Ferrando C; Mellado-Artigas R; Gea A; Arruti E; Aldecoa C; Bordell A; Adalia R; Zattera L; Ramasco F; Monedero P; Maseda E; Martínez A; Tamayo G; Mercadal J; Muñoz G; Jacas A; Ángeles G; Castro P; Hernández-Tejero M; Fernandez J; Gómez-Rojo M; Candela Á; Ripollés J; Nieto A; Bassas E; Deiros C; Margarit A; Redondo FJ; Martín A; García N; Casas P; Morcillo C; Hernández-Sanz ML;
    Rev Esp Anestesiol Reanim (Engl Ed); 2020 Oct; 67(8):425-437. PubMed ID: 32800622
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Phase 3 Open-label, Randomized, Controlled Study to Evaluate the Efficacy and Safety of Intravenously Administered Ravulizumab Compared with Best Supportive Care in Patients with COVID-19 Severe Pneumonia, Acute Lung Injury, or Acute Respiratory Distress Syndrome: A structured summary of a study protocol for a randomised controlled trial.
    Smith K; Pace A; Ortiz S; Kazani S; Rottinghaus S
    Trials; 2020 Jul; 21(1):639. PubMed ID: 32660611
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Severe hypoxemia in a patient with right ventricular myocardial infarction and SARS-CoV-2 infection.
    Albuquerque F; Lopes PM; Brízido C; Strong C; Andrade MJ; de Araújo Gonçalves P; Tralhão A
    BMC Cardiovasc Disord; 2022 Jul; 22(1):334. PubMed ID: 35902795
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Severe Acute Respiratory Syndrome by SARS-CoV-2 Infection or Other Etiologic Agents Among Brazilian Indigenous Population: An Observational Study from the First Year of Coronavirus Disease (COVID)-19 Pandemic.
    Sansone NMS; Boschiero MN; Ortega MM; Ribeiro IA; Peixoto AO; Mendes RT; Marson FAL
    Lancet Reg Health Am; 2022 Apr; 8():100177. PubMed ID: 35018359
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of Clinical Features of Hospitalized Patients Due to the SARS-CoV-2 Infection in the Absence of Comorbidities Regarding the Sex: An Epidemiological Study of the First Year of the Pandemic in Brazil.
    Sansone NMS; Pereira LR; Boschiero MN; Valencise FE; Fraga AMA; Marson FAL
    Int J Environ Res Public Health; 2022 Jul; 19(15):. PubMed ID: 35897265
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pathogenesis-directed therapy of 2019 novel coronavirus disease.
    Stratton CW; Tang YW; Lu H
    J Med Virol; 2021 Mar; 93(3):1320-1342. PubMed ID: 33073355
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.